Alexion splurges in Sweden in bid to build up pipeline

Alexion Pharmaceuticals (Nasdaq: ALXN) has offered 7.1 billion Swedish kronor ($855 million) to buy Stockholm-based Wilson Therapeutics (STO: WTX), by way of a tender offer. The independent committee of the Wilson board has unanimously recommended to shareholders that they accept the offer, ...

0
0